5 Stocks David Cameron Should Consider Buying: GlaxoSmithKline plc, BP plc, Vodafone plc, HSBC Holdings plc & Burberry Group plc

Why David Cameron should be looking at GlaxoSmithKline plc (LON:GSK), BP plc (LON:BP), Vodafone plc (LON:VOD), HSBC Holdings plc (LON:HSBA) and Burberry Group plc (LON:BRBY).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s rumoured David Cameron’s a bit busy at the moment. I don’t suppose he’s looking at stocks for his investment portfolio, but there are plenty of interesting opportunities out there.

Here are the reasons (some serious; some a little less so!) why I think Mr Cameron — and you — might want to consider buying shares in GlaxoSmithKline (LSE: GSK), BP (LSE: BP), Vodafone (LSE: VOD), HSBC (LSE: HSBA) and Burberry (LSE: BRBY).

GlaxoSmithKline

Mr Cameron formed a Business Advisory Group when he got into Downing Street five years ago. Membership of this select group is by personal invitation, and the Prime Minister considers members to be “some of Britain’s leading business men and women”.

Andrew Witty, chief executive of GlaxoSmithKline, is one of the chosen few, so it would seem logical for Mr Cameron to consider buying shares in the pharmaceuticals giant. The company has been battling through a period of patent expiries on some of its leading products. But, with earnings expected to start picking up again next year, and a dividend yield of over 5%, GSK seems an attractive investment, particularly for those seeking income.

BP

Mr Cameron, who waded into battle on behalf of BP after the Gulf of Mexico oil spill in 2010, has now told the company that the UK government would resist any potential foreign takeover of the business.

The Financial Times observed: “BP shareholders have paid for the right to determine the company’s future. The government has not”. The FT has a point. Perhaps now would be a good time for Mr Cameron to buy some BP shares. He could be getting a good deal, too, because the shares, which yield 5.5%, are over 10% below their 52-week high, and could deliver strong returns when the oil price moves higher from its current subdued level.

Vodafone

Mr Cameron seems to like Vodafone. Perhaps the fact that Vodafone UK’s headquarters is in his childhood hometown of Newbury has something to do with it. We’ve seen him popping into HQ to congratulate “this great British success story” for creating new jobs, throwing his weight behind the company in a dispute with the Indian government over a tax liability, and telling us he’s a customer of Vodafone, despite the poor signal he gets when holidaying in Cornwall.

Furthermore, Vodafone chief executive Vittorio Colao is another member of Mr Cameron’s elite Business Advisory Group, and Vodafone is another blue-chip giant currently yielding over 5%.

HSBC

Mr Cameron’s forebears have a long history in finance, but which financial stock would be an appropriate selection for his portfolio. His father, grandfather and great-grandfather were all partners in stockbrokers Panmure Gordon, but this AIM-listed company is a bit on the small side. A great-great-grandfather was the director of the Chartered Bank of India, Australia and China which later became Standard Chartered, but this bank is struggling and in the midst of boardroom changes.

Another of Mr Cameron’s great-great-grandfathers was the London head of the Hongkong and Shanghai Banking Corporation, now HSBC. The UK’s only truly global bank, HSBC seems good value on a low price-to-earnings ratio and with a dividend yield of 5.3%.

Burberry

Mr Cameron’s wife, Samantha, is an ambassador for the British Fashion Council, and is often seen dressed head-to-toe in the best of British labels. Investors who buy a minimum of 250 shares in luxury handbags firm Mulberry are entitled to a 20% discount on up to £5,000 of product per annum. However, the company issued a string of profit warnings last year, and has seen more than its fair share of upheavals and boardroom changes over the years.

Iconic British fashion house Burberry appears a safer bet. While it doesn’t boast the shareholder perks of Mulberry, or the high yields offered by GlaxoSmithKline, BP, Vodafone and HSBC, Burberry has been growing earnings faster than many companies. City analysts are expecting double-digit annual increases for the next two years.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended Burberry, GlaxoSmithKline and HSBC Holdings. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Can this FTSE 250 underperformer turn things around in 2025?

After underperforming since its IPO, shares in Dr Martens have finally started to show some life. Is 2025 the year…

Read more »

Investing Articles

Here’s what £20,000 invested in Rolls-Royce shares at the start of 2024 is worth today

2024 was another brilliant year for Rolls-Royce shares, which almost doubled investors' money. Harvey Jones now wonders if the excitement…

Read more »

Investing Articles

Ahead of its merger with Three, is Vodafone’s share price worth a punt?

The Vodafone share price continues to fall despite the firm’s deal to merge with Three being approved. Could this be…

Read more »

Dividend Shares

3 simple passive income investment ideas to consider for 2025

It’s never been easier to generate passive income from the stock market. Here are three straightforward investment strategies to consider…

Read more »

Investing Articles

I was wrong about the IAG share price last year. Should I buy it in 2025?

The IAG share price soared in 2024 and analysts are expecting more of the same in 2025. So should Stephen…

Read more »

Investing Articles

Here’s the dividend forecast for National Grid shares through to 2027

After a volatile 12 months, National Grid shares are expected to provide a dividend yield of 4.8% for the company’s…

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Growth Shares

2 exceptional growth funds that beat Scottish Mortgage shares in 2024

Scottish Mortgage shares generated double-digit returns for investors in 2024. But these two growth-focused investment funds did much better.

Read more »

Investing Articles

If a 40-year-old put £500 a month in S&P 500 shares, here’s what they could have by retirement

A regular investment in S&P 500 shares could help a middle-aged person build a million-pound portfolio. Royston Wild explains.

Read more »